Live
Clinical OMICsHormone Cell Atlas Maps Body’s Chemical MessengersClinical OMICsSHIMMER: Routine Clinical Data Processed Into Scalable Disease State MarkersEndpoints NewsLilly obesity meds Foundayo and Zepbound to gain CVS coverageEli LillyEli Lilly Stock Heads for Record Close. CVS Weight-Loss Drug Coverage Drives It Higher. - Barron'sIlluminaIllumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research - PR NewswireThermo FisherThermo Fisher Launches E-Gel Power Snap Lite System - Contract PharmaBioPharma DiveGSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’BioWorldAppointments and advancements for May 28, 2026BioWorldFinancings for May 28, 2026BioWorldIn the clinic for May 28, 2026BioWorldOther news to note for May 28, 2026BioWorldRegulatory actions for May 28, 2026
Endpoints News Apr 13, 2026

BioNTech's HER2 ADC succeeds in Phase 2 study, FDA filing planned

BioNTech's HER2 ADC succeeds in Phase 2 study, FDA filing planned

Original
Body unavailable. Use the original source.